Dr. Rosalind Ramsey-Goldman

February 27, 2018 8:01 pm Published by

Dr. Rosalind Ramsey-Goldman is the Solovy Arthritis Research Society Professor in the Division of Rheumatology, Department of Medicine at the Northwestern University Feinberg School of Medicine in Chicago, IL. She directs the Patient-Oriented Clinical Research Program in lupus having had continuous funding for over 25 years from the NIH, foundations, philanthropy, and industry. Her clinical research program examines risk factors to minimize complications related to SLE including cancer, osteoporosis, and cardiovascular disease.

Through national and international collaborations, she has studied genetic risk factors for disease severity and susceptibility in SLE; collaborated on studies to investigate the pathogenesis of disease; developed lupus disease classification criteria, assessed flare occurrence, developed nephritis guidelines, studied biomarkers for diagnosis, and assessed health-related outcomes such as fatigue and quality of life. Many of these clinical investigations incorporate analysis of lupus in multiethnic cohorts examining clinical, laboratory, and health related outcomes highlighting the problems of osteoporosis and cardiovascular disease in African-American women with SLE and providing evidence of worse outcomes based on race/ethnicity and income in SLE patients receiving renal transplants in the setting of end stage renal disease. She is the authors of over 250 scientific publications, the large majority in lupus.

Categorised in:

This post was written by admin